OBJECTIVES To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT®),
a method designed to improve vocal function in patients with Parkinson's disease. …

The purpose of this paper is to provide a cohesive review of the literature regarding the
functional consequences of voice problems and occupational risk factors for them. The salient …

There has been considerable recent research into the connection between Parkinson's
disease (PD) and speech impairment. Recently, a wide range of speech signal processing …

This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal
loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic …

Purpose The vowel space area (VSA) has been used as an acoustic metric of dysarthric
speech, but with varying degrees of success. In this study, the authors aimed to test an …

… Across all recording sessions, data were collected at approximately the same time of day
by the same experimenter (Lorraine O. Ramig). The experimenter did not administer treatment …

The standard reference clinical score quantifying average Parkinson's disease (PD) symptom
severity is the Unified Parkinson's Disease Rating Scale (UPDRS). At present, UPDRS is …

Our 15 years of research have generated the first short-and long-term efficacy data for speech
treatment (Lee Silverman Voice Treatment; LSVT/LOUD) in Parkinson's disease. We have …

Researchers estimate that 89% of people with Parkinson’s disease (PD) have speech and
voice disorders including disorders of laryngeal, respiratory and articulatory function. Despite …

Vocal performance degradation is a common symptom for the vast majority of Parkinson's
disease (PD) subjects, who typically follow personalized one-to-one periodic rehabilitation …